Vir Biotechnology (VIR) PT Raised to $75 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Joseph Stringer raised the price target on Vir Biotechnology (NASDAQ: VIR) to $75.00 while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
